(NASDAQ: KPRX) Kiora Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.7%.
Kiora Pharmaceuticals's earnings in 2024 is $2,669,029.On average, 2 Wall Street analysts forecast KPRX's earnings for 2024 to be $3,475,538, with the lowest KPRX earnings forecast at $2,257,614, and the highest KPRX earnings forecast at $4,693,461.
In 2025, KPRX is forecast to generate -$6,624,315 in earnings, with the lowest earnings forecast at -$8,168,999 and the highest earnings forecast at -$5,079,632.